Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity

The TGF-beta family member myostatin (growth/differentiation factor-8, GDF-8) is a negative regulator of skeletal muscle growth. The hypermuscular Compact mice carry the 12-bp Mstn(Cmpt-dl1Abc) deletion in the sequence encoding the propeptide region of the precursor promyostatin and additional modi...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kocsis Tamás
Trencsényi György
Szabó Kitti
Baán Júlia Aliz
Müller Géza
Mendler Luca
Garai Ildikó
Reinauer Hans
Deák Ferenc
Dux László
Keller-Pintér Anikó
Dokumentumtípus: Cikk
Megjelent: 2017
Sorozat:AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM 312 No. 3
doi:10.1152/ajpendo.00216.2016

mtmt:3156200
Online Access:http://publicatio.bibl.u-szeged.hu/13603
LEADER 02963nab a2200325 i 4500
001 publ13603
005 20180706155042.0
008 180706s2017 hu o 0|| zxx d
022 |a 0193-1849 
024 7 |a 10.1152/ajpendo.00216.2016  |2 doi 
024 7 |a 3156200  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Kocsis Tamás 
245 1 0 |a Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity  |h [elektronikus dokumentum] /  |c  Kocsis Tamás 
260 |c 2017 
300 |a E150-E160 
490 0 |a AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM  |v 312 No. 3 
520 3 |a The TGF-beta family member myostatin (growth/differentiation factor-8, GDF-8) is a negative regulator of skeletal muscle growth. The hypermuscular Compact mice carry the 12-bp Mstn(Cmpt-dl1Abc) deletion in the sequence encoding the propeptide region of the precursor promyostatin and additional modifier genes of the Compact genetic background contribute to determine the full expression of the phenotype. In this study, by using mice strains carrying mutant or wild-type myostatin alleles with Compact genetic background, and non-mutant myostatin with wild-type background we studied separately the effect of the Mstn(Cmpt-dl1Abc) mutation or the Compact genetic background on morphology, metabolism and signaling. We show that both the Compact myostatin mutation and Compact genetic background account for determination of skeletal muscle size. Despite the increased musculature of Compacts, the absolute size of heart and kidney are not influenced by myostatin mutation; however, the Compact genetic background increases them. Both Compact myostatin and genetic background exhibit systemic metabolic effects. The Compact mutation decreases adiposity, improves whole body glucose uptake, insulin sensitivity and 18FDG uptake of skeletal muscle and white adipose tissue, while the Compact genetic background has opposite effect. Importantly, the mutation does not prevent the formation of mature myostatin; however, a decrease in myostatin level was observed leading to altered activation of Smad2, Smad1/5/8 and Akt, and increased level of pAS160, a Rab-GTPase activating protein responsible for GLUT4 translocation. Based on our analysis the Compact genetic background strengthens the effect of myostatin mutation on muscle mass, but can compensate each other when systemic metabolic effects are compared. 
700 0 1 |a Trencsényi György  |e aut 
700 0 1 |a Szabó Kitti  |e aut 
700 0 1 |a Baán Júlia Aliz  |e aut 
700 0 1 |a Müller Géza  |e aut 
700 0 1 |a Mendler Luca  |e aut 
700 0 1 |a Garai Ildikó  |e aut 
700 0 1 |a Reinauer Hans  |e aut 
700 0 1 |a Deák Ferenc  |e aut 
700 0 1 |a Dux László  |e aut 
700 0 2 |a Keller-Pintér Anikó  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/13603/1/ajpendo.00216.2016.pdf  |z Dokumentum-elérés